Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology.Using MAP technology, Tempo is building functional tissue and organs within patients, in real time, to treat disease, and developing next-generation vaccine technologies that are shelf stable, stockpile-able, and protect against multiple diseases with a single injection. Our mission is to use MAP material technology to enable the future of medicine.
View Top Employees from Tempo TherapeuticsWebsite | http://www.tempothera.com |
Revenue | $2 million |
Employees | 17 (10 on RocketReach) |
Founded | 2014 |
Address | 3977 Georgia St 6, San Diego, California 92103, US |
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Pharmaceuticals |
Competitors | AgeX Therapeutics, Inc., Boehringer Ingelheim Venture Fund, Cellular Engineering Technologies Inc., The Column Group |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Tempo Therapeutics employee's phone or email?
The Tempo Therapeutics annual revenue was $2 million in 2024.
Stéphanie Deshayes is the Director of Research of Tempo Therapeutics.
10 people are employed at Tempo Therapeutics.
Tempo Therapeutics is based in San Diego, California.
The NAICS codes for Tempo Therapeutics are [5417, 541714, 541, 54171, 54].
The SIC codes for Tempo Therapeutics are [873, 87].